Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer

E-ISSN： 1873-4286|16|29|3288-3299

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.29, 2010-10, pp. : 3288-3299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3246-3254

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic Anhydrase Inhibitors and the Management of Cancer

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 865-878

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of carbonic anhydrase activity and its applications in therapy

By Scozzafava Andrea Mastrolorenzo Antonio Supuran Claudiu T

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 667-702

Informa Healthcare

Access to resources Recommend Favorite

Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 – 2009

By Poulsen Sally-Ann

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. : 795-806

Informa Healthcare

Access to resources Recommend Favorite

Carbonic Anhydrase Related Protein VIII and its Role in Neurodegeneration and Cancer

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3264-3276

Bentham Science Publishers

Access to resources Recommend Favorite